USA-based Thomson Scientific says it has enhanced Thomson Pharma, its drug discovery and development information platform, with the addition of a Brand Management Module for product, brand and franchise managers in the pharmaceutical industry, to help develop effective messaging and positioning for their products.
Thomson says that the module basically provides users with the ability to measure the potential impact of scientific information on their products from the point of view of the prescribing clinician. Within Thomson Pharma, the Brand Management Module assigns an evidence-based credibility score and aggregates a range of key message metrics to deliver graphic and statistical analyses based on information from scientific literature and medical meetings that describe the user's products.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze